Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Lilly expands product options for Ligand

March 11, 1998

New ACAT-inhibitory malondiamido derivatives from Sanwa

March 10, 1998

First approval for RPR's new combination patch

March 10, 1998

Antithromboxane therapy leads to clinical benefit in type II diabetics

March 9, 1998

Droxia approved by FDA for sickle cell anemia

March 6, 1998

Mechanism of insulinotropic action of BTS-67582 explored in B-cells

March 5, 1998

New agents for lowering blood glucose and plasma triglycerides

March 5, 1998

Antidiabetic agents in development at Boehringer Mannheim

March 4, 1998

University of Alabama describes delta-EKLFs for hemoglobinopathies

March 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...